Acute otitis media symptoms and symptom scales in research with Aboriginal and Torres Strait Islander children.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
25
06
2022
accepted:
29
12
2022
entrez:
23
2
2023
pubmed:
24
2
2023
medline:
3
3
2023
Statut:
epublish
Résumé
Aboriginal and Torres Strait Islander children experience a high burden of otitis media. We collected data on symptoms associated with acute otitis media (AOM) in a clinical trial involving children receiving primary care at urban Aboriginal Medical Services. Two scales were employed to monitor symptoms over time: the AOM-Severity of Symptoms scale (AOM-SOS) and the AOM-Faces Scale (AOM-FS). This study took place at a mid-point of the un-blinded trial. We examined symptoms at enrolment and day 7, and compared the scales for trends, and bivariate correlation (Spearman's rho) over 14 days. Responsiveness of the scales to clinical change was determined by Friedman's test of trend in two subgroups stratified by day 7 AOM status. We interviewed parents/carers and research officers regarding their experience of the scales and analysed data thematically. Data derived from 224 children (18 months to 16 years; median 3.6 years). Common symptoms associated with AOM at baseline were runny nose (40%), cough (38%) and irritability (36%). More than one third had no or minimal symptoms at baseline according to AOM-SOS (1-2/10) and AOM-FS scores (1-2/7). The scales performed similarly, and were moderately correlated, at all study points. Although scores decreased from day 0 to 14, trends and mean scores were the same whether AOM was persistent or resolved at day 7. Users preferred the simplicity of the AOM-FS but encountered challenges when interpreting it. We found minimally symptomatic AOM was common among Aboriginal and Torres Strait Islander children in urban settings. The AOM-SOS and AOM-FS functioned similarly. However, it is likely the scales measured concurrent symptoms related to upper respiratory tract infections, given they did not differentiate children with persistent or resolved AOM based on stringent diagnostic criteria. This appears to limit the research and clinical value of the scales in monitoring AOM treatment among Aboriginal and Torres Strait Islander children.
Sections du résumé
BACKGROUND
Aboriginal and Torres Strait Islander children experience a high burden of otitis media. We collected data on symptoms associated with acute otitis media (AOM) in a clinical trial involving children receiving primary care at urban Aboriginal Medical Services. Two scales were employed to monitor symptoms over time: the AOM-Severity of Symptoms scale (AOM-SOS) and the AOM-Faces Scale (AOM-FS). This study took place at a mid-point of the un-blinded trial.
METHODS
We examined symptoms at enrolment and day 7, and compared the scales for trends, and bivariate correlation (Spearman's rho) over 14 days. Responsiveness of the scales to clinical change was determined by Friedman's test of trend in two subgroups stratified by day 7 AOM status. We interviewed parents/carers and research officers regarding their experience of the scales and analysed data thematically.
RESULTS
Data derived from 224 children (18 months to 16 years; median 3.6 years). Common symptoms associated with AOM at baseline were runny nose (40%), cough (38%) and irritability (36%). More than one third had no or minimal symptoms at baseline according to AOM-SOS (1-2/10) and AOM-FS scores (1-2/7). The scales performed similarly, and were moderately correlated, at all study points. Although scores decreased from day 0 to 14, trends and mean scores were the same whether AOM was persistent or resolved at day 7. Users preferred the simplicity of the AOM-FS but encountered challenges when interpreting it.
CONCLUSION
We found minimally symptomatic AOM was common among Aboriginal and Torres Strait Islander children in urban settings. The AOM-SOS and AOM-FS functioned similarly. However, it is likely the scales measured concurrent symptoms related to upper respiratory tract infections, given they did not differentiate children with persistent or resolved AOM based on stringent diagnostic criteria. This appears to limit the research and clinical value of the scales in monitoring AOM treatment among Aboriginal and Torres Strait Islander children.
Identifiants
pubmed: 36821636
doi: 10.1371/journal.pone.0280926
pii: PONE-D-22-18129
pmc: PMC9949645
doi:
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0280926Informations de copyright
Copyright: © 2023 Abbott et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pediatrics. 2010 May;125(5):e1154-61
pubmed: 20368317
Acad Emerg Med. 2002 Mar;9(3):199-202
pubmed: 11874775
Pediatr Infect Dis J. 2009 Jan;28(1):5-8
pubmed: 19077917
Laryngoscope. 2003 Oct;113(10):1645-57
pubmed: 14520089
Trials. 2016 Mar 03;17(1):119
pubmed: 26941013
Pediatr Infect Dis J. 2015 Mar;34(3):e41-3
pubmed: 25259933
Pediatrics. 2013 Mar;131(3):e964-99
pubmed: 23439909
J Laryngol Otol. 2014 Jan;128 Suppl 1:S16-27
pubmed: 24359614
J Pediatric Infect Dis Soc. 2015 Dec;4(4):367-9
pubmed: 26582877
BMJ Open. 2020 May 5;10(5):e035343
pubmed: 32371515
BMC Pediatr. 2018 Dec 20;18(1):392
pubmed: 30572868
N Engl J Med. 2011 Jan 13;364(2):105-15
pubmed: 21226576
Int J Pediatr Otorhinolaryngol. 2016 Feb;81:55-9
pubmed: 26810291
Pediatr Infect Dis J. 2006 Feb;25(2):101-7
pubmed: 16462284
BMC Fam Pract. 2017 Nov 29;18(1):96
pubmed: 29187141
Scand J Prim Health Care. 2000 Mar;18(1):25-9
pubmed: 10811039
BMC Pediatr. 2005 Jul 20;5:27
pubmed: 16033643
Med J Aust. 2009 Nov 2;191(S9):S60-4
pubmed: 19883359
Nat Rev Dis Primers. 2016 Sep 08;2:16063
pubmed: 27604644
Acad Pediatr. 2012 May-Jun;12(3):214-8
pubmed: 22459064
Microbiome. 2018 Nov 5;6(1):199
pubmed: 30396360
PLoS One. 2012;7(10):e47711
pubmed: 23082199
Pediatrics. 2010 Nov;126(5):e1168-98
pubmed: 20921070
Pediatr Infect Dis J. 2009 Jan;28(1):9-12
pubmed: 19077916
Int J Pediatr Otorhinolaryngol. 2019 Jul;122:170-174
pubmed: 31035175
BMJ Open. 2021 Dec 24;11(12):e050839
pubmed: 34952874